Clifford Chance Advised Haier Group In Global Regulatory Filings For Acquisition Of 20% Equity Stake In Shanghai RAAS

Clifford Chance Advised Haier Group In Global Regulatory Filings For Acquisition Of 20% Equity Stake In Shanghai RAAS

Clifford Chance, a Global Law Firm, provided Legal Counsel to Haier Group for the Global Regulatory Filings related to its acquisition of a 20% equity stake in blood products company Shanghai RAAS from Grifols, S.A., valued at RMB12.5 billion (approximately US$1.8 billion).

Lead Partner Yong Bai said, "We are pleased to have successfully assisted Haier in this significant investment which expands their portfolio into higher-growth sectors like healthcare. This transaction demonstrates our strong capabilities in navigating the complexity of global regulations, and our commitment to supporting our clients' growth ambitions."

Yong Bai received Support from Counsel Dayu Man in Hong Kong and trainee Lawyer Ziwen Wang in Beijing. The intricate transaction also Involved Lawyers from Clifford Chance's Global Network, as well as local Counsel from various jurisdictions:

Washington D.C.: Partners Renee Latour, Timothy Cornell, and Brian Concklin, Alongside Associates Holly Bauer, Erica Hackett, and Amber Pirson.

Madrid: Partners Jaime Almenar and Miguel Odriozola, Counsel Begoña Barrantes, Senior Associate Diego Doménech, and Lawyer Luisa Morely.

Barcelona: Senior Counsel Carme Briera.

Paris: Partner Katrin Schallenberg, Associates Antoine Réco, Hendrik Coppoolse, and Marlen Pezzetta, and Trainee Lawyer Flore Petitot.

Casablanca: Casablanca Managing Partner Mustapha Mourahib and Associate Hasnaa Bennani.

Click to know more about Clifford Chance